Corlieve Therapeutics closed a Seed round (amount undisclosed) in Nov 2020. The company is based in Paris, France. Investors in the round: Idinvest Partners, Kurma Partners, Pureos Bioventures. Data as of 7 Aug 2026.
Amount undisclosed or unconverted.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
This is the company's only recorded round.
